Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 13 » default
Degenerative Neurological and Neuromuscular Disease
ISSN: 1179-9900
- View all (129)
- Volume 14, 2024 (5)
- Volume 13, 2023 (10)
- Volume 12, 2022 (11)
- Volume 11, 2021 (6)
- Volume 10, 2020 (4)
- Volume 9, 2019 (11)
- Volume 8, 2018 (8)
- Volume 7, 2017 (10)
- Volume 6, 2016 (11)
- Volume 5, 2015 (12)
- Volume 4, 2014 (13)
- Volume 3, 2013 (8)
- Volume 2, 2012 (14)
- Volume 1, 2011 (6)
Archive: Volume 13, 2023
- default (10)
- Therapeutic options in chronic neurodegeneration: from experimental research to clinical practice (6)
Current Perspectives: Obesity and Neurodegeneration - Links and Risks
Kueck PJ, Morris JK, Stanford JA
Degenerative Neurological and Neuromuscular Disease 2023, 13:111-129
Published Date: 3 January 2024
Development and Validation of a Risk Prediction Model to Estimate the Risk of Stroke Among Hypertensive Patients in University of Gondar Comprehensive Specialized Hospital, Gondar, 2012 to 2022
Chekol YM, Merid MW, Tesema GA, Tesfie TK, Tebeje TM, Gelaw NB, Gebi NB, Seretew WS
Degenerative Neurological and Neuromuscular Disease 2023, 13:89-110
Published Date: 14 December 2023
Practical Guidance on the Use of Cladribine Tablets in the Management or Relapsing Multiple Sclerosis: Expert Opinion from Qatar
Deleu D, Garcia Canibano B, Elalamy O, Sayed Abdelmoneim M, Boshra A
Degenerative Neurological and Neuromuscular Disease 2023, 13:81-88
Published Date: 13 December 2023
Neuroprotective Effects of Leptin on the APP/PS1 Alzheimer’s Disease Mouse Model: Role of Microglial and Neuroinflammation
Ma J, Hou YH, Liao ZY, Ma Z, Zhang XX, Wang JL, Zhu YB, Shan HL, Wang PY, Li CB, Lv YL, Wei YL, Dou JZ
Degenerative Neurological and Neuromuscular Disease 2023, 13:69-79
Published Date: 25 October 2023
Interventions to Improve Quality of Life in Multiple Sclerosis: New Opportunities and Key Talking Points
Faraclas E
Degenerative Neurological and Neuromuscular Disease 2023, 13:55-68
Published Date: 19 September 2023
Risk of Obstructive Sleep Apnea in Saudi Male Boys with Duchenne Muscular Dystrophy (DMD)
Bamaga A, Alqarni L
Degenerative Neurological and Neuromuscular Disease 2023, 13:45-53
Published Date: 15 August 2023
Sexual Motivation in Persons with Multiple Sclerosis: A Controlled Cross-Sectional Study
Prinssen P, Jongen PJ, Heerings M, Wyverkens E, T'Sjoen G, Deschepper E, Dewitte M
Degenerative Neurological and Neuromuscular Disease 2023, 13:33-44
Published Date: 28 June 2023
Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
Jakimovski D, Wicks TR, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R
Degenerative Neurological and Neuromuscular Disease 2023, 13:21-32
Published Date: 1 February 2023
Ultrasound-Guided Percutaneous Neuromodulation in Multiple Sclerosis: A Case Report
Javier-Ormazábal A, Herrero P, González-Platas M
Degenerative Neurological and Neuromuscular Disease 2023, 13:15-20
Published Date: 27 January 2023
Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson’s Disease: What We Know so Far
Sivagurunathan N, Gnanasekaran Priyadharshini, Calivarathan L
Degenerative Neurological and Neuromuscular Disease 2023, 13:1-13
Published Date: 26 January 2023